Prospective analysis of outcomes and economic factors of same-day bilateral cataract surgery in the United States

Journal of Cataract and Refractive Surgery
Sloan W RushRyan B Rush

Abstract

To evaluate the visual and economic benefits of same-day bilateral cataract surgery versus separate-day bilateral cataract surgery in the United States. Private practice, Amarillo, Texas, USA. Prospective controlled nonrandomized clinical trial. A cohort of patients having same-day bilateral cataract surgery was age-matched with a cohort of control patients who had standard separate-day bilateral cataract surgery. The primary outcome was a comparison of the direct cost for the patient, physician, ambulatory surgery center (ASC), and third-party payer. The same-day cohort (42 patients, 84 eyes) had similar baseline characteristics and postoperative outcomes as the control cohort (42 patients, 84 eyes). The same-day cohort had less total distance traveled for care (P = .0039 and P < .0001 for in-town and out-of-town residents, respectively), less total time spent traveling for care (P = .0008 and P < .0001 for in-town and out-of-town residents, respectively), less total number of visits required for care (P < .0001), and less total time for vision recovery (P < .0001) than the control cohort. The physician and ASC reimbursements were lower in the same-day cohort (P = .0028 and P = .0016, respectively), whereas the total physician...Continue Reading

References

Aug 6, 2003·Journal of Cataract and Refractive Surgery·Steve A ArshinoffRonit Yagev
Jun 5, 2004·Journal of Cataract and Refractive Surgery·Anna-Ulrika SarikkolaLeila Laatikainen
Jun 13, 2006·Journal of Cataract and Refractive Surgery·Gerard Ainsworth
Dec 13, 2006·American Journal of Ophthalmology·Martin SalmFrank A Sloan
Aug 19, 2007·Indian Journal of Ophthalmology·Mohsen Bahmani KashkouliMasood Naseripour
Nov 26, 2008·Journal of Cataract and Refractive Surgery·Steve Arshinoff
Apr 1, 2009·Japanese Journal of Ophthalmology·J K ChungSung Jin Lee
Sep 28, 2010·Journal of Cataract and Refractive Surgery·Emanuel S Rosen
Nov 23, 2010·Current Opinion in Ophthalmology·Amar Agarwal, Dhivya Ashok Kumar
Apr 19, 2011·Journal of Cataract and Refractive Surgery·Anna-Ulrika SarikkolaTero Kivelä
Nov 24, 2011·Journal of Cataract and Refractive Surgery·Steve A Arshinoff, Paul A Bastianelli
Jul 4, 2013·Journal of Cataract and Refractive Surgery·Heidrun E GolloglyJay C Erie
Nov 20, 2013·Ophthalmology·Gary C BrownPhilip A Lieske

❮ Previous
Next ❯

Citations

Sep 30, 2016·Current Opinion in Ophthalmology·Ranjodh SinghGrace Sun
Nov 18, 2017·Clinical & Experimental Ophthalmology·Timothy V Roberts, Shawn Li
Dec 21, 2019·Journal of Cataract and Refractive Surgery·Emily C MillsChristopher S C Liu
Dec 23, 2016·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Andrzej GrzybowskiCharles Claoué
Apr 16, 2017·Journal of Cataract and Refractive Surgery·Neal H ShorsteinLisa J Herrinton
Dec 4, 2019·Asia-Pacific Journal of Ophthalmology·David F Chang
May 1, 2021·Eye·Shruti ChandraMayank A Nanavaty
May 21, 2021·Indian Journal of Ophthalmology·Suresh K Pandey, Vidushi Sharma
Jul 2, 2021·JAMA Ophthalmology·Fasika A Woreta, Oliver D Schein
Aug 28, 2021·International Journal of Environmental Research and Public Health·Diana Anna DmuchowskaIwona Obuchowska
Jul 2, 2021·JAMA Ophthalmology·Julia P OwenUNKNOWN IRIS Research Analytic Center Consortium
Sep 29, 2021·American Journal of Ophthalmology·James A CarolanMatthew Carnahan
Sep 6, 2020·Ophthalmology·Iqbal Ike K AhmedSteve A Arshinoff
Sep 22, 2020·Ophthalmology·Samuel Masket

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.